tetano
Editor, Senior Moderator
Intern Med J
. 2023 Jul 14.
doi: 10.1111/imj.16145. Online ahead of print. Risk of venous thromboembolism in COVID-19 infection
Meeri Honkanen[SUP] 1 [/SUP], Simo Sirkeoja[SUP] 1 [/SUP], Hanna Viskari[SUP] 1 [/SUP], Ville Kailankangas[SUP] 1 [/SUP], Marjatta Sinisalo[SUP] 1 [/SUP], Jaana Syrjänen[SUP] 1 [/SUP]
Affiliations
The incidence of venous thromboembolism (VTE) for non-hospitalised patients with coronavirus disease-2019 infection has not been very widely studied. 13 019 persons with a positive SARS-CoV-2 nucleic acid amplification test were identified. In total, 447 (0.2%) VTEs were identified in the study population, 293 (66%) of these were pulmonary embolisms. A positive SARS-CoV-2 test did not increase the risk for VTE in the univariate analysis (odds ratio (OR): 1.0, 95% confidence interval (CI): 0.69-1.4) or multivariable analysis (OR: 1.36, 95% CI: 0.93-1.97).
Keywords: COVID-19; epidemiology; outpatients; pulmonary embolism; venous thromboembolism.
. 2023 Jul 14.
doi: 10.1111/imj.16145. Online ahead of print. Risk of venous thromboembolism in COVID-19 infection
Meeri Honkanen[SUP] 1 [/SUP], Simo Sirkeoja[SUP] 1 [/SUP], Hanna Viskari[SUP] 1 [/SUP], Ville Kailankangas[SUP] 1 [/SUP], Marjatta Sinisalo[SUP] 1 [/SUP], Jaana Syrjänen[SUP] 1 [/SUP]
Affiliations
- PMID: 37449583
- DOI: 10.1111/imj.16145
The incidence of venous thromboembolism (VTE) for non-hospitalised patients with coronavirus disease-2019 infection has not been very widely studied. 13 019 persons with a positive SARS-CoV-2 nucleic acid amplification test were identified. In total, 447 (0.2%) VTEs were identified in the study population, 293 (66%) of these were pulmonary embolisms. A positive SARS-CoV-2 test did not increase the risk for VTE in the univariate analysis (odds ratio (OR): 1.0, 95% confidence interval (CI): 0.69-1.4) or multivariable analysis (OR: 1.36, 95% CI: 0.93-1.97).
Keywords: COVID-19; epidemiology; outpatients; pulmonary embolism; venous thromboembolism.